The AML had overall gained 4 mutations in cancer genes: ETV1 (p.R405H, VAF 30.4%), KRAS (p.G12A, VAF 27.9%), PARP1 (c.2277 + 1G > C, VAF 7.5%), and ETV6 (p.I358M, VAF 5.3%). This evidence concerns the gene ETV6 and acute myeloid leukemia.